Skip to content

INSYTE with SurePlanTM LiverY90

INSYTE with SurePlanTM LiverY90

Insyte

Collaboration between Sirtex Medical and MIM Software Inc. advances innovation and increases precision of liver-directed oncology therapies for patients.

SurePlan

Key Features

 

Inyte Logo

insyte


MIM Software Inc. is the legal manufacturer of the SurePlan LiverY90 Software.
SurePlan is a trademark of MIM Software Inc.
mim

Intended Use / Indications For Use: SIR-Spheres Y-90 resin microspheres are approved or licensed for use in Australia, Singapore, Malaysia, South Korea and several other countries in Asia for the treatment of patients with advanced non-operable liver cancer. Consult Instructions for Use for a complete listing of indications, contraindications, side effects, warnings, and precautions.